SCHEMBL4625922

SCHEMBL4625922

CCCCCc1ncccc1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KCNH2 Q12809 2/20 0.40
PPARA Q07869 1/20 0.40
GRM2 Q14416 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
DHFR P00374 1/20 0.36
TRPV1 Q8NER1 2/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 2/20 0.34
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9143648 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL28130836 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL28676139 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL29467768 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL28667999 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL1469935 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL28680286 0.98 TDP1 (0.47) TDP1L3MBTL1KCNH2PPARAGRM2
SCHEMBL10268371 0.94 L3MBTL1 (0.42) TDP1L3MBTL1PPARAGRM2CYP3A4
SCHEMBL3066461 0.86 PDE3B (0.38) L3MBTL1GRM2NPC1RAB9AKDM4E
SCHEMBL11100271 0.81 HRH1 (0.49) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102344410-A Arylpyridine ortho-position monohalogenated compounds and synthesis method thereof UNIV SHANGHAI 2012-02-08 CN disclosed
EP-1948605-A2 MODULATORS OF THE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-07-30 EP disclosed
WO-2007061741-A2 MODULATORS OF THE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-05-31 WO disclosed